RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Clair Obscur: Expedition 33 is full of twists, turns, and world-changing events even before reaching the final act. So, it trusts that you’ve been paying full attention well before the final battle.